Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics, Inc. logo
NLTX

Neoleukin Therapeutics, Inc. (NLTX)

$0.421.3%

Market is closed
– opens on 8 PM, 12 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$0.4
Day's Range
$0.4485
$0.375
52-Week Range
$5.69
1 month return19.63%
3 month return60.75%
1 year return91.75%
5 year return95.83%

Company Information

Neoleukin is a biopharmaceutical company creating next generation immunotherapies for cancer, inflammation and autoimmunity using de novo protein design technology. Neoleukin uses sophisticated computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins. Neoleukin's lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to improve tolerability and activity by eliminating the alpha receptor binding interface.
OrganizationNeoleukin Therapeutics, Inc.
Employees77
CEODr. Jonathan G. Drachman M.D.
IndustryHealth Technology

Analyst Recommendation

based on 7 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 7 Wall street analysts offering stock ratings for Neoleukin Therapeutics, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 490.48%

Current

$0.42

Target

$2.48

Recommendation Trend

Based on 7 analyst

Current1M Ago3M Ago
Buy
7
11
12
Hold
0
1
1
Sell
0
1
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
17.7M
Book Value
$2.48
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.11
Wall Street Target Price
2.48

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
0.19
Enterprise Value
-74996251
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
1.31

Technicals

Beta
1.14
50 Day MA
0.55
200 Day MA
1.12

Institutional Holdings

Baker Bros Advisors LP

8.97%

Redmile Group, LLC

8.07%

Millennium Management LLC

4.97%

Point72 Asset Management, L.P.

4.85%

Renaissance Technologies Corp

3.79%

Vanguard Group Inc

2.41%

Discover more

Frequently Asked Questions

What is Neoleukin Therapeutics, Inc. share price today?

Can Indians buy Neoleukin Therapeutics, Inc. shares?

How can I buy Neoleukin Therapeutics, Inc. shares from India?

Can Fractional shares of Neoleukin Therapeutics, Inc. be purchased?

What are the documents required to start investing in Neoleukin Therapeutics, Inc. stocks?

What are today’s High and Low prices of Neoleukin Therapeutics, Inc.?

What are today’s traded volumes of Neoleukin Therapeutics, Inc.?

What is today’s market capitalisation of Neoleukin Therapeutics, Inc.?

What is the 52 Week High and Low Range of Neoleukin Therapeutics, Inc.?

How much percentage Neoleukin Therapeutics, Inc. is down from its 52 Week High?

How much percentage Neoleukin Therapeutics, Inc. is up from its 52 Week low?

What are the historical returns of Neoleukin Therapeutics, Inc.?

Who is the Chief Executive Officer (CEO) of Neoleukin Therapeutics, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*